By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Keryx Biopharmaceuticals 

750 Lexington Avenue, 26th Floor

New York  New York  10022  U.S.A.
Phone: 212-531-5965 Fax: 212-531-5961



Company News
Keryx (KERX) Announces Case Study Data Of Auryxia Presented At American Society of Nephrology’s Kidney Week 11/21/2016 10:47:26 AM
Keryx (KERX) Announces Multiple Scientific Presentations Of Phase III Trial Results Of Ferric Citrate For Iron Deficiency Anemia (IDA) In Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD) 11/18/2016 7:33:39 AM
Keryx (KERX) Announces U.S. FDA Approval Of Second Contract Manufacturer For Auryxia (Ferric Citrate) 11/10/2016 1:55:40 PM
Keryx (KERX) Announces Third Quarter 2016 Financial Results And Provides Corporate Update 11/9/2016 7:49:47 AM
Keryx (KERX) To Host Conference Call Of Third Quarter 2016 Financial Results On Wednesday, November 9, 2016 11/1/2016 10:44:46 AM
Keryx (KERX) To Webcast Its Presentation At Ladenburg Thalmann’s 2016 Healthcare Conference 9/21/2016 10:33:31 AM
Keryx (KERX) To Present At Two Upcoming Investor Healthcare Conferences 9/1/2016 8:18:42 AM
Keryx (KERX) Shares Fall After Manufacturing of Drug is Halted 8/2/2016 11:41:18 AM
Keryx (KERX) To Host Conference Call Of Second Quarter 2016 Financial Results On Monday, August 1, 2016 7/29/2016 8:25:12 AM
Douglas Jermasek To Join Keryx (KERX) As Vice President, Marketing And Strategy 6/27/2016 11:09:31 AM